• Explore /
  • Poster
  • / Phase II randomized study of abiraterone acetate plus ADT versus apalutamide versus abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels. (LACOG 0415).

Phase II randomized study of abiraterone acetate plus ADT versus apalutamide versus abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels. (LACOG 0415).

Abstract Poster

Authors

Fernando Cotait Maluf

Fernando C. Maluf

Centro Oncológico Antônio Ermirio de Morais - BP Beneficencia Portuguesa de São Paulo, São Paulo, Brazil

Fernando C. Maluf , Oren Smaletz , Fabio A. B. Schutz , Vinicius Carrera Souza , Andre Poisl Fay , Daniel Herchenhorn , Gustavo Werutsky , Telma Murias Santos

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral and Testicular Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT02867020

Citation

J Clin Oncol 36, 2018 (suppl 6S; abstr TPS404)

DOI

10.1200/JCO.2018.36.6_suppl.TPS404

Abstract #

TPS404

Poster Bd #

N2

Abstract Disclosures

Similar Posters

First Author: Alicia K. Morgans

First Author: Guillaume Grisay

First Author: Tian Zhang

First Author: Jian Guan